Jean Malo - Actelion Member of the Board of Directors

Director

Mr. Jean P. Malo was Member of the Board of Directors of Actelion Ltd since 2004. He is Member of the Finance and Audit Committee of the Company. He received an MBA from Essec, Paris France, in 1977. He is a Chartered Financial Analyst, and Member of the Association for Investment Management and Research, and the Houston Society of Financial Analysts. As of April 2013, he serves as Managing Director of AVALON ADVISORS, LLC. He joined Breen Investors L.P., a Houstonbased investment advisor, in 2000 where he served as a Senior Partner and Chief Investment Officer until 2008. He was Chief Investment Officer for Vaughan Nelson Scarborough and McCullough, a Houstonbased affiliate of Metropolitan Life. From 1989 to 1997, he managed both equity and fixed income portfolios for Daniel Breen and Company, an affiliate of Banque Indosuez, in Houston. From 1978 to 1989, he was a corporate banker for Banque Indosuez in Saudi Arabia, then in Houston, and finally in New York, where he was in charge of fixed income derivatives sales. Between 1977 and 1978, he was a financial analyst at the French Embassy in Singapore. since 2004.
Age 61
Tenure 20 years
Professional MarksMBA
Phone41 61 565 65 65
Webhttp://www.actelion.com
Malo received an MBA from Essec, Paris France, in 1977. He is a Chartered Financial Analyst, and Member of the Association for Investment Management and Research, and the Houston Society of Financial Analysts. As of April 2013, he serves as Managing Director of AVALON ADVISORS, LLC. He joined Breen Investors L.P., a Houstonbased investment advisor, in 2000 where he served as a Senior Partner and Chief Investment Officer until 2008. He was Chief Investment Officer for Vaughan Nelson Scarborough and McCullough, a Houstonbased affiliate of Metropolitan Life. From 1989 to 1997, he managed both equity and fixed income portfolios for Daniel Breen and Company, an affiliate of Banque Indosuez, in Houston. From 1978 to 1989, he was a corporate banker for Banque Indosuez in Saudi Arabia, then in Houston, and finally in New York, where he was in charge of fixed income derivatives sales. Between 1977 and 1978, he was a financial analyst at the French Embassy in Singapore.

Actelion Management Efficiency

The company has return on total asset (ROA) of 23.87 % which means that it generated a profit of $23.87 on every $100 spent on assets. This is very large. Similarly, it shows a return on equity (ROE) of 47.08 %, meaning that it generated $47.08 on every $100 dollars invested by stockholders. Actelion's management efficiency ratios could be used to measure how well Actelion manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

DIRECTOR Age

Richard MillikenRyanair Holdings PLC
66
Charles McCreevyRyanair Holdings PLC
67
Fiona KearnsRyanair Holdings PLC
N/A
John WilsonWizz Air Holdings
49
Roisin BrennanRyanair Holdings PLC
53
Michael HorganRyanair Holdings PLC
77
Billy McCoyBoyd Gaming
73
Michael CawleyRyanair Holdings PLC
63
Louise PhelanRyanair Holdings PLC
50
Lauri ShanahanCedar Fair LP
57
Richard FlahertyBoyd Gaming
73
Mike OBrienRyanair Holdings PLC
73
Edward WilsonRyanair Holdings PLC
53
Paul WhetsellBoyd Gaming
70
Peter ThomasBoyd Gaming
71
Stan McCarthyRyanair Holdings PLC
59
Susan HooperWizz Air Holdings
58
Matthew HartAir Lease
69
James OsborneRyanair Holdings PLC
67
Debra SmithartOglesbyCedar Fair LP
65
Ian SainesAir Lease
58
Actelion Ltd, a biopharmaceutical company, discovers, develops, and commercializes low molecular weight drugs for unmet medical needs. The company was founded in 1997 and is headquartered in Allschwil, Switzerland. Actelion Ltd is traded on OTC Market in USA. Actelion Ltd UNSP [ALIOY] is a Pink Sheet which is traded between brokers over the counter.

Management Performance

Actelion UNSP Leadership Team

Elected by the shareholders, the Actelion's board of directors comprises two types of representatives: Actelion inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Actelion. The board's role is to monitor Actelion's management team and ensure that shareholders' interests are well served. Actelion's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Actelion's outside directors are responsible for providing unbiased perspectives on the board's policies.
Rudi Frank, Senior Vice President Head Global Quality Management, Member of the Extended Executive Committee
Marian Borovsky, Senior Vice President Group General Counsel, Member of the Extended Executive Committee, Corporate Secretary to the Board of Directors
Thomas Widman, Co-Founder
Nicholas Franco, Executive Vice President Chief Business Development Officer, Member of the Executive Committee
Christian Albrich, Senior Vice President Head Global Human Resources and a member of the Extended Actelion Executive Committee
Martine Clozel, Senior Vice President Chief Scientific Officer, Head of Drug Discovery, Pharmacology & Preclinical Development, Member of the Extended Executive Committee
Robert Bertolini, Member of the Board of Directors
Juhani Anttila, Member of the Board of Directors
JeanPierre Garnier, Chairman of the Board of Directors
David Stout, Member of the Board of Directors
JeanPaul Clozel, CEO, Member of the Executive Committee, Delegate of the Board of Directors
Guy Braunstein, Executive Vice President Head of Global Clinical Development, Member of the Executive Committee
Herna Verhagen, Member of the Board of Directors
Andrew Weiss, Senior Vice President Head Investor Relations and Corporate Communications, Member of the Extended Executive Committee
Michael Jacobi, Member of the Board of Directors
Jean Malo, Member of the Board of Directors
Otto Schwarz, COO, Executive Vice President Member of the Executive Committee
Andre Muller, CFO, Executive Vice President Member of the Executive Committee
Peter Gruss, Member of the Board of Directors
John Greisch, Member of the Board of Directors

Actelion Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Actelion a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Actelion in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Actelion's short interest history, or implied volatility extrapolated from Actelion options trading.

Pair Trading with Actelion

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Actelion position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Actelion will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Consideration for investing in Actelion Pink Sheet

If you are still planning to invest in Actelion UNSP check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Actelion's history and understand the potential risks before investing.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
CEOs Directory
Screen CEOs from public companies around the world
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Global Correlations
Find global opportunities by holding instruments from different markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges